Category: cancer care

Child Cancer Experts Stress on Early Identification of Symptoms for Better Outcomes

Posted on by City Today News (City today.media)

Over 50,000 children are afflicted by cancer every year in India


BENGALURU / February 14, 2024: The incidence of child cancer in India is approximately 38-124 per million children with over 50,000 children being diagnosed with the dreaded disease each year.  This incidence has been increasing over the last two-three decades. This was said by cancer experts of Sammprada Hospital, a leading cancer hospital in Bengaluru.

Said Dr.Intezar Mehdi, Consultant Paediatrics Oncology and Hematalogy, Sammprada Hospital, Bengaluru: “In majority of cancer cases in children, the exact cause is not known. In a few cases, genetic, environmental and infections may play a role. The good news is that paediatric cancers cure rates are much better than cancer in adults as the disease biology is different. In the West, 80-85% of child patients of cancer are fully cured. In India, cure rates have been improving in the last couple of decades. To increase outcomes, it is important that symptoms are recognized early, and treatment begins the earlier possible.”

Talking about the serious signs and symptoms of cancer in children that parents should not ignore, he said: “Generally signs and symptoms of childhood cancer are non-specific and subtle. High index of suspicion is the key to early diagnosis. Parents should watch out for unexplained fever, weight loss and night sweats, glands in the neck, armpit or groin, headaches, vomiting and seizures or neurological problems, swelling in the abdomen or chest and bone pains and swelling, and bleeding or pallor. These symptoms may be early warning signs of cancer in children.”

Leukemia, lymphomas and brain tumors are the most common cancers in children. Wilms tumor, neuroblastoma, bone tumors, soft tissue tumors, and liver and eye tumors are other common ones.

Dr.Suma ,Consultant Paediatrics Oncology, Sammprada Hospital, Bengaluru ,There is a wide care gap between the availability of services in rural areas compared to urban areas. This gap needs to be bridged. Government schemes for treatment of child cancer are essential. Better collaboration between government and the private sector, as well as between state, national and international agencies would go a long way in improving the situation for children with cancer in the country. Philanthropic NGOs can play a big role in ensuring treatment for thousand child patients each year.”

City Today News 9341997936

Apollo Cancer Centres Introduces Indias Fastest & Most Precise Breast Cancer Diagnosis, Redefining Cancer Care

Posted on by City Today News (City today.media)


~In lieu of Breast Cancer Awareness Month in October, this pioneering initiative signifies Apollo Cancer Centres dedication to women’s health and the fight against breast cancer~

Bangalore, 31st October 2023: Apollo Cancer Centres (ACCs) continues to push the boundaries with advanced cancer treatment, by introducing Indias Fastest & Most Precise Breast Cancer Diagnosis Program’. This pioneering initiative aims to provide swift and precise breast cancer diagnoses, reinforcing the significance of early detection in mitigating the right treatment for a better survival rate, and enhancing the quality of life for patients.
This groundbreaking initiative marks a significant stride toward breast cancer management and offers a promising glimpse into the future of healthcare services. Apollo Cancer Centres is proud to be the first in India to provide this program and envisions the potential to replicate the model for other organs in the future. In alignment with Breast Cancer Awareness Month in October, Apollo Cancer Centres is dedicating this program to the timely diagnosis of breast cancer in women.
Breast cancer is a prevailing concern for women’s health, and timely diagnosis is the cornerstone of effective intervention. Early detection is paramount in the fight against breast cancer, and we at Apollo Cancer Centre, have achieved a great level of success in treating breast cancer diagnosed in the early stages. We have accomplished breast conservation rates up to 60%, and are able to de-escalate therapy as per global evidence-based guidelines, hence offering our patients superior quality of life outcomes.

Indias Fastest & Most Precise Breast Cancer Diagnosis Program’ is designed to ensure timely and accurate diagnosis, alleviating the stress of protracted waiting times for results. Apollo Cancer Centres firmly believes in the adage, “Earliest Easiest,” when it comes to breast cancer management.
This program includes advanced diagnostic technologies, including mammography, ultrasound, and biopsy, to promptly and precisely assess breast health. Patients can expect results within 24 hours, a testament to the program’s efficiency. It is open to individuals seeking breast cancer screening or diagnostic services, provided they meet the necessary criteria. Its primary benefits encompass rapid results, reduced patient anxiety, and early detection of breast canceradvancements that significantly improve treatment outcomes.
Diagnostic tests employed are generally safe and minimally invasive, with healthcare professionals dedicated to ensuring patient comfort throughout the process. Cost variations may arise depending on location, insurance coverage, and specific diagnostic requirements, for which patients could reach out to Apollo Cancer Centres for precise information. In case of breast cancer being detected, Apollo Cancer Centres program is equipped to guide patients toward personalized care, connecting them with skilled oncologists and specialists for a comprehensive treatment plan.”
Dr Jayanti Thumsi- Lead Surgeon – Breast Oncology, Apollo Cancer Centre, Bangalore, said, “Our mission at Apollo Cancer Centres is to revolutionize cancer care through innovation and compassion. The 24 hours Breast Cancer Diagnosis Program is a significant stride in this direction. We understand the fear and anxiety that often accompanies a cancer diagnosis. With this program, we aim to reduce those burdens by providing women with rapid, precise diagnoses and a clear path towards tailored treatments on need basis. Every minute counts, and we are determined to make every moment count for the betterment of our patients.”

Dr. Manish Mattoo – Chief Executive Officer Karnataka Region, Apollo Hospitals said,  “The launch of Indias First, Fastest & Precise Diagnosis program is a testament to our unwavering commitment to redefining cancer care. We believe that time is of the essence when it comes to breast cancer. Our goal is to provide hope and healing swiftly, offering women the timely and accurate diagnoses they deserve. With this program, we are not just reducing wait times; we are elevating patient outcomes, ensuring early intervention, and spreading the message of empowerment and resilience.”
Dr Govindarajan M J Sr. Consultant – Radiology Apollo Cancer Centre, Bangalore, said,.”We recognise that an early diagnosis of breast cancer can be a turning point in a patient’s journey; achieving this quickly and accurately goes a long way in reducing patients’ anxiety and facilitates faster acceptance and timely treatment, which in turn improves the outcomes. The launch of India’s fastest & most precise breast cancer diagnosis program, represents our commitment to swift, precise diagnoses and tailored treatments. It’s not just about detecting cancer but providing empowerment, reassurance, and the best possible care to our patients when they need it the most.”
Dr Aruna R Patil-Senior Consultant Radiologist, Apollo Cancer Centre, Bangalore, said, ” Our commitment to breast cancer diagnosis and care goes beyond just medical excellence; it extends to ensuring our patients are feeling empowered and supported. We understand that early diagnosis leads to better outcomes and improved quality of life. With our One-Day Cancer Diagnosis Program for Breast Cancer in Women, we aim to offer not only timely results but also a path to hope and recovery. This program allows us to combine our expertise with advanced diagnostic tools to deliver timely and accurate diagnosis. It is about providing the best care when our patients need it most.
Dr Swarna Shivkumar- Senior Consultant Pathologist, Apollo Cancer Centre, BangaloreOur mission at Apollo Cancer Centres is to revolutionize cancer care through innovation and compassion. The One-Day Breast Cancer Diagnosis Program is a significant stride in this direction. We understand the fear and anxiety that often accompany a cancer diagnosis. With this program, we aim to reduce those burdens by providing women with rapid, precise diagnoses and a clear path toward tailored treatments on need basis. Every minute counts, and we are determined to make every moment count for the betterment of our patients.”

City Today News 9341997936

HCG Cancer Hospital Bengaluru Achieves Remarkable Milestone in Head and Neck Cancer Treatment with Low Dose Immunotherapy

Posted on by City Today News (City today.media)

~A successful pilot study has shown tremendous results on Head and Neck Cancer Patients

Bengaluru, September 13, 2023 – HCG Cancer Hospital Bengaluru, one of India’s leading cancer care chains, is proud to announce a groundbreaking pilot study to transform the treatment landscape for head and neck cancer patients with Low Dose Immunotherapy. Known for its relentless commitment to innovation and value-based care since its inception in 1989, HCG is taking a significant step towards advancing cancer care in India and globally. The successful pilot study on Low Dose Immunotherapya Nivolumab with NACT has demonstrated remarkable efficacy and is highly cost-effective, providing an economical therapy option without additional side effects.

The multicentric, open-labeled, prospective, randomized study assesses the effectiveness of neoadjuvant therapy combining low-dose immunotherapy Nivolumab and the TPF regimen (docetaxel, cisplatin, and 5-fluorouracil) compared to NACT with the TPF regimen alone. It has a potential role in improving the quality of life and longevity of patients with locally advanced carcinoma of the buccal mucosa.

As part of the pilot study, a total of 12 cases were studied between the age group of 54 to 76 years. All twelve patients experienced significant tumor reduction of over 90%, providing an economical and side effect-free therapy through low-dose immunotherapy. In the pilot study, standard neoadjuvant chemotherapy is combined with low-dose Nivolumab immunotherapy, administering 40 mg every two weeks, as opposed to the full dose of 3 mg per kg of body weight.

Speaking at the occasion, Dr. B S Ajaikumar, Executive Chairman of Healthcare Global Enterprises Limited, said, “HCG has been tirelessly striving to serve the larger cause of cancer care through a breakthrough innovation and value-based care. Cancer is fast becoming a chronic disease, and a sear change has occurred in how we stage cancer as we adopt a multi-disciplinary approach to treatment. At HCG, head and neck cancer cases represent a significant portion of the caseload. Despite thea comprehensive approach, preventing the recurrence and spread of these cancers remains a significant challenge. Today, with this announcement, we embark on a journey to revolutionize head and neck cancer treatment. This study has the potential to be a game-changer in the sphere of head and neck cancera treatment. The initiative reflects HCG’s commitment to advancing research and academia in India,a positioning the organization as a leader in this vital healthcare domain.”

Dr. Satheesh C T, Consultant – Medical and Hemato Oncology, Director of Clinical Trials HCG Cancer Hospital Bangalore, said, ” Head and neck cancers pose a substantial global health issue, comprising 4.5% of total worldwide cancer cases with a mortality rate of 4.6%. The burden is exceptionally high in Asia, notably in India, where they make up nearly 35% of all cancer cases among individuals aged 40-60. We are enthusiastic about the potential benefits of combining low-dose immunotherapy with neoadjuvant chemotherapy in head and neck cancers. This study presents a cost-effective solution without compromising the quality of care. This approach not only delivers promising clinical results but also in a manner that is highly economical for patients.”

Enthused by these promising findings, HCG will initiate a study to explore the potential benefits of low cancers dose immunotherapy alongside neoadjuvant chemotherapy in head and neck cancers. Through this study
spanning across multiple HCG centers in India, HCG will strive to unfold a highly effective and affordable cancer treatment option in the management of head and neck cancers.

City Today News 9341997936

Namma Bengaluru Cancer Survivors walkathon was Flagged off by Dr. Ashu Shah-Founder of Ashu shah cancer Foundation.

Posted on by City Today News (City today.media)

Ashu Shah cancer Foundation is so proud to have supported thousands of Cancer patients ,we’ve witnessed thousands of stories of resilience, courage and strength dedication, and success.

The Namma Bengaluru Shero – Cancer Survivors walkathon was flagged off by – Dr Ashu shah founder of ASC Foundation along with Doctors and cancer Survivors @ Lalbagh Botanical Garden Bengaluru #SareeRun on 26 th August 2023

We expressed our heartfelt gratitude to all the bravehearts (Veers and Veeranganas) who have made the supreme sacrifice for the country.Meri Maati Mera Desh.

Dr Ashu shah addressed gathering with :

Dear all fighters! You are doing an awesome job! Salute to You all. Keep it up! You can do it. Hats off to you all .

Dr Ashu shah senior Consultant founder of ASC Foundation said You can’t stop the waves, but you can learn to surf.”Together, let’s fight through the waves. A big shout out to all cancer survivors !

Awake! Arise and go! Never ever give up! you will never walk alone. –Never never never give up.”–
nothing is impossible. With prayers, love and courage ,you all have won the battle over cancer.

cancer is so limited. It cannot cripple love. It cannot shatter hope. It cannot corrode faith. It cannot destroy peace. It cannot conquer the spirit. #Hope

The Shero is derived from survivor Hero ,These are the victors brave than CANCER hence called Sheros.

The Survivors Hope Group is all about love hope courage survival only to boost You, help you to overcome from this deadly disease .#cancer

I know It’s challenging, but you all have to eat right and exercise walk 45mints /meditate /Yoga after your chemotherapy it’s the best medicine to keep you active & helps you to prevent further Remissions/Relapse

Wellness is the complete integration of body, mind, and spirit – the realization that everything we do, think, feel, and believe has an effect on our state of well-being.
Wellness encompasses a healthy body, a sound mind, and a tranquil spirit. Enjoy the journey as you strive for wellness said Dr Ashu shah

Dr. Ashu shah said we are one of the Leading organisation in India in Cancer Screening both Breast and cervical cancer our Team of Doctors and Scientists Screen approximately 10,000 women in a month .

She said Molecular profiling for precision cancer therapies is only the way forward. Cervical cancer is one of the leading cancer around the globe caused by HPV, a very common group of viruses. Just 2 high-risk HPV strains (16 and 18) cause more than 70% of cervical cancers, but can be treated if detected early enough. So, alongside nation-wide vaccination of girls against HPV #vaccine
DNA-based testing for human papillomavirus (HPV) has been shown to be more effective than today’s commonly used screening methods on cytology commonly known as a “Pap smear” detecting and preventing cervical cancer, a major cause of death among women worldwide- Dr Ashu Shah

Dr Poonam Maurya Consultant medical oncologist emphasized the importance of holistic wellness in the journey of patients including Mindfulness, gratitude , and joy of living and celebrating Life .

More than 200 people participated in Saree run / Walkathon @ Botinical garden Lal bagh

The Whole Event was presided by Ashu Shah cancer Foundation & Asian HealthCare

Ashu Shah Cancer Foundation
Asian Healthcare centre of Excellence
Asian Healthcare and Rehabilitation

Dr #ashushah Dr #PoonamMaurya

CancerSurvivorsDay #cancerresearch #Walkathon #SareeRun #AsianOncology #earlydetectioncansavelives #healthambassador

Asianpinkribbon #AsianHealthcare

cancerawareness #cancersurvivor #ashushah

MeriMaatiMeraDesh #VeeronKaVandan

Courage #Strength #CancerisConquerable

City Today News 9341997936

Research Grants Endowed with €240,000

Posted on by City Today News (City today.media)

DKMS supports Promising young scientists in advancing blood cancer therapy

August 3, 2023 – On August 1, 2023, the application period for the DKMS John Hansen Research Grant 2024 began. The DKMS Stiftung Leben Spenden supports up to four outstanding research projects in the field of stem cell transplantation or cell therapy each year. The grant is aimed at young scientists who have obtained a doctoral degree (PhD, MD or equivalent achievements) no more than 10 years ago. The grant amounts to €240,000 each and will be paid out over a period of three years. The application deadline is November 30, 2023.
DKMS is primarily known as the world’s largest stem cell donor center, with more than 11.5 million registered potential stem cell donors. However, the non-profit organization is also deeply involved in the medical and scientific field. “Every year, more than 1.2 million people around the world are diagnosed with blood cancer and, though a stem cell transplant can save the lives of many of them, not all patients are permanently cured afterwards,” explains Professor Dr. Marcel van den Brink, Chairman of the DKMS Medical Council. “Still, relapses and severe complications, most notably graft-versus-host disease, pose major challenges to medicine and science. We want to contribute to the continuous improvement of stem cell transplantation and other cellular therapies.” To this end, DKMS runs its own research projects and is committed to ensuring excellent research for the future. “It is a matter close to our heart and the DKMS John Hansen Research Grant enables talented young scientists to work on their promising projects for the benefit of patients worldwide.”
All information on the application modalities, as well as further details on the John Hansen Research Grant, are available on the DKMS Professionals’ Platform. If you have any questions, interested parties are also welcome to contact DKMS by email: grant@dkms.org.
DKMS – much more than a stem cell donor center
To date, DKMS has already given more than 105,000 blood cancer patients a second chance at life. In addition, the non-profit organization operates its own research unit in Dresden. With the DKMS Life Science Lab, it has the most powerful HLA typing laboratory in the world. DKMS research teams work on many different scientific studies around the topic of stem cell transplantation. One particularly successful example is the first DKMS clinical trial with practice-changing results. As a result of the trial, more patients worldwide may have access to transplantation in the future. If you would like to find out more about the scientific commitment of the non-profit organization, you will find detailed information on the DKMS Professionals’ Platform.
John A. Hansen – outstanding physician with a big heart
John A. Hansen, after whom the grant is named, was an outstanding oncologist and distinguished immunogeneticist at the renowned Fred Hutchinson Cancer Research Center in Seattle. With his excellent achievements in the field of hematopoietic stem cell transplantation, this dedicated and empathetic physician made a significant contribution to increasing the efficacy and safety of blood stem cell and bone marrow transplantations – and thus helped in giving countless patients a second chance at life. As a long-standing member of the board of the DKMS Stiftung Leben Spenden and a member of the DKMS Medical Council, he was deeply connected to the DKMS family.

City Today News 9341997936